Prognostic, chemotherapy and immunotherapy roles of GPR37/GPR37L1 in pan-cancer.

Medicine (Baltimore) · 2026 · PMC12975191 · PMID 41790623

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = .061so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Additionally, SKCM patients with low GPR37 expression showed a trend toward longer overall survival following immunotherapy, though this difference did not reach statistical significance ( P = .061; hazard ratio [HR] = 1.77, 95% CI 0.92–3.02; Fig. 7 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.